We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Heron Therapeutics
HRTX
$60.3M
| $176K | ﹤0.01% |
50,270
+570
| +1% | +$1.75K |
|
1502
SSR Mining
SSRM
$7.18B
| $176K | ﹤0.01% |
38,947
-2,127
| -5% | -$10.9K |
|
1503
Celanese
CE
$5.14B
| $170K | ﹤0.01% |
1,260
+906
| +256% | +$138K |
|
1504
3D Systems Corp
DDD
$522M
| $169K | ﹤0.01% |
55,180
+9,860
| +22% | +$36.2K |
|
1505
Monolithic Power Systems
MPWR
$56.4B
| $169K | ﹤0.01% |
206
-179
| -46% | -$129K |
|
|
ENV
1506
DELISTED
ENVESTNET, INC.
ENV
| $169K | ﹤0.01% |
2,700
+1,200
| +80% | +$75.5K |
|
1507
Air Products & Chemicals
APD
$63.9B
| $168K | ﹤0.01% |
651
-2
| -0.3% | -$507 |
|
1508
Wolfspeed
WOLF
$1.25B
| $168K | ﹤0.01% |
7,368
-1,274
| -15% | -$32.9K |
|
1509
CONMED
CNMD
$1.41B
| $167K | ﹤0.01% |
+2,402
| New | +$175K |
|
1510
BILL Holdings
BILL
$4.18B
| $164K | ﹤0.01% |
3,108
+1,651
| +113% | +$93.4K |
|
1511
Clearway Energy Class C
CWEN
$6.15B
| $160K | ﹤0.01% |
6,464
-353
| -5% | -$8.93K |
|
|
CTLT
1512
DELISTED
CATALENT, INC.
CTLT
| $159K | ﹤0.01% |
2,833
+2,324
| +457% | +$130K |
|
1513
PG&E
PCG
$29.4B
| $155K | ﹤0.01% |
8,873
-209
| -2% | -$3.68K |
|
1514
Red Robin
RRGB
$138M
| $153K | ﹤0.01% |
20,275
-219,724
| -92% | -$1.6M |
|
1515
Consolidated Edison
ED
$39B
| $152K | ﹤0.01% |
1,696
-32,352
| -95% | -$3M |
|
1516
Pebblebrook Hotel Trust
PEB
$2.01B
| $151K | ﹤0.01% |
11,000
| – | – |
|
1517
Hormel Foods
HRL
$11.4B
| $150K | ﹤0.01% |
4,929
+2,895
| +142% | +$97.4K |
|
1518
Edwards Lifesciences
EW
$51.5B
| $150K | ﹤0.01% |
1,624
-201
| -11% | -$17.8K |
|
1519
Genuine Parts
GPC
$18B
| $147K | ﹤0.01% |
1,065
-13,303
| -93% | -$1.98M |
|
1520
AerCap
AER
$22.4B
| $146K | ﹤0.01% |
1,567
+1,060
| +209% | +$94.4K |
|
1521
Oportun Financial
OPRT
$359M
| $145K | ﹤0.01% |
50,000
-40,000
| -44% | -$121K |
|
|
WSR
1522
DELISTED
Whitestone REIT
WSR
| $144K | ﹤0.01% |
10,840
-764
| -7% | -$9.39K |
|
|
OPLN
1523
Openlane
OPLN
$4.28B
| $144K | ﹤0.01% |
8,675
-29,188
| -77% | -$501K |
|
1524
BBB Foods
TBBB
$6.08B
| $143K | ﹤0.01% |
+6,000
| New | +$140K |
|
1525
Regions Financial
RF
$24.3B
| $142K | ﹤0.01% |
7,110
-474
| -6% | -$9.19K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.